Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
Ezetimibe/simvastatin is an efficacious and tolerated treatment
June 13th, 2005
Ezetimibe/simvastatin is good treatment option for hypercholesterolemic patients. According to recent research from the United States, "Low-density lipoprotein cholesterol (LDL-C) is the primary therapeutic target in the National Cholesterol Education Program Adult Treatment Panel III (ATP III) guidelines. This study tested the hypothesis that ezetimibe/simvastatin, a lipid-lowering agent that inhibits both intestinal cholesterol absorption and cholesterol synthesis, provides greater LDL-C reductions than atorvastatin across dose ranges." "This multicenter, double-blind, 6-week parallel-group study randomized 1902 patients with LDL-C above ATP III...
Source: Health & Medicine Week (2005-06-13)
|
